Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-048627
Filing Date
2021-12-16
Accepted
2021-12-16 18:49:03
Documents
2
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1613
2 EX-24 DOCUMENT attachment1.htm EX-24 3066
  Complete submission text file 0000899243-21-048627.txt   6153
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALECTOR, INC 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address
Kenkare-Mitra Sara (Reporting) CIK: 0001895592 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38792 | Film No.: 211499103